成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

4-methyl-1,5,7,9-tetrazabicyclo[4.3.0]nona-3,5,7-trien-2-one

4-methyl-1,5,7,9-tetrazabicyclo[4.3.0]nona-3,5,7-trien-2-one Struktur
35523-67-2
CAS-Nr.
35523-67-2
Englisch Name:
4-methyl-1,5,7,9-tetrazabicyclo[4.3.0]nona-3,5,7-trien-2-one
Synonyma:
5-Methyl-3H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one;5-Methyl-4H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one;5-METHYL-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7(3H)-ONE;[1,2,4]Triazolo[1,5-a]pyrimidin-7(1H)-one, 5-methyl-;4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine;4-methyl-1,5,7,9-tetrazabicyclo[4.3.0]nona-3,5,7-trien-2-one
CBNumber:
CB23226267
Summenformel:
C6H6N4O
Molgewicht:
150.14
MOL-Datei:
35523-67-2.mol

4-methyl-1,5,7,9-tetrazabicyclo[4.3.0]nona-3,5,7-trien-2-one Eigenschaften

Schmelzpunkt:
278 °C(Solv: ethanol (64-17-5))
Siedepunkt:
421.6±28.0 °C(Predicted)
Dichte
1.60±0.1 g/cm3(Predicted)
pka
0.58±0.40(Predicted)
EPA chemische Informationen
[1,2,4]Triazolo[1,5-a]pyrimidin-7(1H)-one, 5-methyl- (35523-67-2)

Sicherheit

4-methyl-1,5,7,9-tetrazabicyclo[4.3.0]nona-3,5,7-trien-2-one Chemische Eigenschaften,Einsatz,Produktion Methoden

4-methyl-1,5,7,9-tetrazabicyclo[4.3.0]nona-3,5,7-trien-2-one Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

6-CHLORO-5-METHYL-4H-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-ONE

4-methyl-1,5,7,9-tetrazabicyclo[4.3.0]nona-3,5,7-trien-2-one Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 6)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-66113011 18112977050
 cb5@aikonchem.com China 10526 58
  • 4-methyl-1,5,7,9-tetrazabicyclo[4.3.0]nona-3,5,7-trien-2-one
  • 5-Methyl-3H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one
  • 5-METHYL-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7(3H)-ONE
  • 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine
  • 5-Methyl-4H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one
  • [1,2,4]Triazolo[1,5-a]pyrimidin-7(1H)-one, 5-methyl-
  • 35523-67-2
Copyright 2019 ? ChemicalBook. All rights reserved